Schulhoff & Co’s Eli Lilly LLY Stock Holding History

Schulhoff & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.79M	Hold	4,825	–	–	2.32%	11
2026 Q1	$4.44M	Sell	4,825 -25	-0.5%	-$25.3K	1.82%	15
2025 Q4	$5.21M	Buy	4,850 +8	+0.2%	+$7.65K	2.19%	12
2025 Q3	$3.69M	Hold	4,842	–	–	1.58%	15
2025 Q2	$3.77M	Hold	4,842	–	–	1.67%	14
2025 Q1	$4M	Hold	4,842	–	–	1.77%	15
2024 Q4	$3.74M	Sell	4,842 -18	-0.4%	-$14.9K	1.36%	16
2024 Q3	$4.31M	Sell	4,860 -20	-0.4%	-$18K	1.8%	14
2024 Q2	$4.42M	Hold	4,880	–	–	1.99%	12
2024 Q1	$3.8M	Sell	4,880 -200	-4%	-$142K	1.66%	15
2023 Q4	$2.96M	Sell	5,080 -30	-0.6%	-$17.5K	1.41%	19
2023 Q3	$2.74M	Sell	5,110 -65	-1%	-$33.5K	1.39%	18
2023 Q2	$2.43M	Hold	5,175	–	–	1.13%	24
2023 Q1	$1.78M	Hold	5,175	–	–	0.83%	36
2022 Q4	$1.89M	Hold	5,175	–	–	0.87%	32
2022 Q3	$1.67M	Hold	5,175	–	–	0.87%	35
2022 Q2	$1.68M	Hold	5,175	–	–	0.78%	37
2022 Q1	$1.48M	Hold	5,175	–	–	0.62%	46
2021 Q4	$1.43M	Hold	5,175	–	–	0.59%	47
2021 Q3	$1.2M	Buy	5,175 +50	+1%	+$12.3K	0.54%	49
2021 Q2	$1.18M	Sell	5,125 -130	-2%	-$26.1K	0.52%	49
2021 Q1	$981K	Sell	5,255 -620	-11%	-$121K	0.45%	52
2020 Q4	$991K	Sell	5,875 -500	-8%	-$74.7K	0.5%	47
2020 Q3	$943K	Hold	6,375	–	–	0.51%	47
2020 Q2	$1.05M	Sell	6,375 -225	-3%	-$34.5K	0.62%	42
2020 Q1	$915K	Hold	6,600	–	–	0.57%	43
2019 Q4	$867K	Hold	6,600	–	–	0.41%	55
2019 Q3	$738K	Sell	6,600 -500	-7%	-$55.7K	0.36%	59
2019 Q2	$786K	Hold	7,100	–	–	0.41%	58
2019 Q1	$921K	Buy	7,100 +175	+3%	+$21.3K	0.49%	52
2018 Q4	$801K	Sell	6,925 -225	-3%	-$25.1K	0.5%	51
2018 Q3	$767K	Hold	7,150	–	–	0.43%	54
2018 Q2	$610K	Sell	7,150 -2,100	-23%	-$172K	0.36%	60
2018 Q1	$715K	Hold	9,250	–	–	0.42%	54
2017 Q4	$781K	Hold	9,250	–	–	0.44%	52
2017 Q3	$791K	Buy	9,250 +50	+0.5%	+$4.1K	0.47%	49
2017 Q2	$757K	Hold	9,200	–	–	0.46%	49
2017 Q1	$773K	Hold	9,200	–	–	0.48%	50
2016 Q4	$676K	Sell	9,200 -200	-2%	-$14.9K	0.42%	52
2016 Q3	$754K	Hold	9,400	–	–	0.46%	48
2016 Q2	$740K	Hold	9,400	–	–	0.46%	48
2016 Q1	$676K	Hold	9,400	–	–	0.44%	49
2015 Q4	$792K	Hold	9,400	–	–	0.54%	45
2015 Q3	$786K	Hold	9,400	–	–	0.56%	46
2015 Q2	$784K	Hold	9,400	–	–	0.5%	47
2015 Q1	$682K	Hold	9,400	–	–	0.42%	50
2014 Q4	$648K	Hold	9,400	–	–	0.39%	51
2014 Q3	$610K	Hold	9,400	–	–	0.38%	56
2014 Q2	$584K	Buy	9,400 +1,300	+16%	+$77.6K	0.36%	58
2014 Q1	$477K	Hold	8,100	–	–	0.32%	55
2013 Q4	$413K	Hold	8,100	–	–	0.28%	63
2013 Q3	$408K	Hold	8,100	–	–	0.29%	60
2013 Q2	$398K	Buy	+8,100	New	+$441K	0.3%	59

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Schulhoff & Co's LLY Position: Q2 2026 in Review

Schulhoff & Co held its Eli Lilly (LLY) position steady in Q2 2026 at 4,825 shares worth $5.79M. The position accounts for 2.32% of the portfolio, ranked #11.

Schulhoff & Co first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Schulhoff & Co held 4,825 shares of Eli Lilly worth $5.79M as of Q2 2026.
Schulhoff & Co left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 2.32% of Schulhoff & Co's portfolio in Q2 2026, its #11 holding.
Schulhoff & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Schulhoff & Co's 13F filing for Q2 2026, filed 13 Aug 2026.